Diamidex
PrivateLast Round
Crowdfunding
Jun 2, 2025
Est. Valuation
$16.15M
Total Funding Raised
$3.11M
Company Overview
Diamidex operates in Healthcare & Life Sciences and is based in Marseille. Its latest recorded funding round was a Crowdfunding round in June 2025.
Diamidex is a biotechnology company that develops, manufactures, and sells a range of innovative solutions, including equipment, software, and reagents, to detect and count targeted microorganisms.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Environmental Monitoring, Water Treatment
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diamidex Comparables
Compare Diamidex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lonza Group | 83% | |
| rqmicro AG | 82% | |
| Nanoplasmas | 74% |
For institutional investors. Book with your work email.
Diamidex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jun 2, 2025 | ||||
| Grant | May 21, 2024 | ||||
| VC Round | Nov 8, 2023 | ||||
| VC Round | Oct 2, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Diamidex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TotalEnergies Développement Régional | VC Round |
| PureTerra Ventures | Crowdfunding, VC Round |
| Rugby Angels | VC Round |
| French Ministry of Ecological Transition | Grant |
| ADEME - Agence de la transition écologique | Grant |
| Bpifrance | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 77% MoM, from 219 to 388.
- Feb 19, 2026
Grew 25% QoQ from 28 to 35 employees.
For institutional investors. Book with your work email.
Diamidex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Diamidex's valuation, stock price, and market status.
Is Diamidex a public or private company?
Diamidex is a private company.
What is the current stock price of Diamidex?
Diamidex is a private company, so its shares have no public market price. Caplight tracks Diamidex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Diamidex worth (valuation)?
Diamidex's valuation is estimated at $16.1M based on funding round data.
Can I buy Diamidex stock?
Diamidex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Diamidex's last funding round?
Diamidex's most recent funding round was Crowdfunding on June 2, 2025.
Who are the main investors in Diamidex?
Key investors in Diamidex include PureTerra Ventures.
Will Diamidex IPO soon?
No public IPO plans have been announced for Diamidex.
How can I track Diamidex secondary market activity?
Caplight tracks bids, offers, and trades in Diamidex's shares on secondary markets.